Saffron Supplementation for Dry AMD: Italy
Description: The Catholic University of the Sacred Heart in Italy is conducting a 30-person clinical trial of saffron for the treatment of dry age-related macular degeneration (AMD). Saffron contains high concentrations of crocin and crocetin, compounds with anti-oxidative properties. Saffron supplementation has inhibited retinal degeneration in lab studies.
Trial Status: Recruiting participants.
Partial List of Participation Criteria:
- 55 years of age or older
- Diagnosis of early dry AMD
Clinical Trial Contact:
Benedetto Falsini, M.D.
Phone: 0039063015 ext. 4929
Policlinico A. Gemelli
Saffron clinical trial for dry AMD listing on ClinicalTrials.gov